Dorato Capital Management
Source: SEC Form 13F · as of Mar 2026Dorato Capital Management holds 17 biotech & pharma companies tracked by BioSniper, totaling $9.8M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$9.8M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 9,408 | $2.3M |
| MRKMerck & Co., Inc. | 16,370 | $2.0M |
| AMGNAMGEN INC | 4,824 | $1.7M |
| ABBVAbbVie Inc. | 4,099 | $867K |
| CAHCardinal Health Inc. | 3,537 | $761K |
| MCKMcKesson Corporation | 695 | $605K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,964 | $601K |
| NVSNovartis AG | 2,104 | $325K |
| ABTABBOTT LABORATORIES | 3,034 | $314K |
| CORCencora Inc. | 407 | $132K |
| GILDGILEAD SCIENCES, INC. | 565 | $80K |
| ELVElevance Health Inc. | 110 | $35K |
| LLYELI LILLY & Co | 34 | $32K |
| PFEPFIZER INC | 655 | $18K |
| BMYBRISTOL MYERS SQUIBB CO | 300 | $18K |
| NVONovo Nordisk A/S | 126 | $5K |
| GEHCGE HealthCare Technologies Inc. | 1 | $75 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.